[
  {
    "title": "打造规模化医药产业业务体系 达嘉维康拟收购天济草堂85.7143%股份",
    "href": "http://stock.jrj.com.cn/2022/12/22131837231008.shtml",
    "datetime": "2022-12-22 13:18:52",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：拟3.41亿元收购天济草堂85.71%股份 加快向上游医药工业布局",
    "href": "http://stock.jrj.com.cn/2022/12/22115637230845.shtml",
    "datetime": "2022-12-22 11:56:36",
    "code": "301126"
  },
  {
    "title": "A股异动丨达嘉维康跌近6% 重要股东和高管拟合计减持不超7.07%股份",
    "href": "http://stock.jrj.com.cn/2022/12/08112637197496.shtml",
    "datetime": "2022-12-08 11:26:04",
    "code": "301126"
  },
  {
    "title": "达嘉维康：股东拟合计减持不超7%公司股份",
    "href": "http://stock.jrj.com.cn/2022/12/07154837194933.shtml",
    "datetime": "2022-12-07 15:48:49",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：量吉投资方面、董事钟雪松拟合计减持不超7.07%股份",
    "href": "http://stock.jrj.com.cn/2022/12/07154837194940.shtml",
    "datetime": "2022-12-07 15:48:28",
    "code": "301126"
  },
  {
    "title": "【龙虎榜】达嘉维康12月5日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/05180037189382.shtml",
    "datetime": "2022-12-05 18:00:18",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：约7300.91万股限售股将于12月7日解禁上市",
    "href": "http://stock.jrj.com.cn/2022/12/02171637184859.shtml",
    "datetime": "2022-12-02 17:16:24",
    "code": "301126"
  },
  {
    "title": "【龙虎榜】达嘉维康11月29日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/29180037175063.shtml",
    "datetime": "2022-11-29 18:00:34",
    "code": "301126"
  },
  {
    "title": "【龙虎榜】达嘉维康11月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/18180037150634.shtml",
    "datetime": "2022-11-18 18:00:18",
    "code": "301126"
  },
  {
    "title": "【龙虎榜】达嘉维康11月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/17180037147297.shtml",
    "datetime": "2022-11-17 18:00:19",
    "code": "301126"
  },
  {
    "title": "拟自筹资金收购天济草堂85.71%股份，达嘉维康20%涨停",
    "href": "http://stock.jrj.com.cn/2022/11/17103237145882.shtml",
    "datetime": "2022-11-17 10:32:21",
    "code": "301126"
  },
  {
    "title": "A股异动 | 达嘉维康20CM涨停 拟收购天济草堂85.71%股份",
    "href": "http://stock.jrj.com.cn/2022/11/17100937145793.shtml",
    "datetime": "2022-11-17 10:09:04",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：拟购天济草堂85.71%股份 欲进一步拓展产业链上游",
    "href": "http://stock.jrj.com.cn/2022/11/16163537143764.shtml",
    "datetime": "2022-11-16 16:35:56",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：第三季度净利降2.81%至1466.36万元",
    "href": "http://stock.jrj.com.cn/2022/10/25214237083502.shtml",
    "datetime": "2022-10-25 21:42:20",
    "code": "301126"
  },
  {
    "title": "【龙虎榜】达嘉维康8月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/08/17180036908717.shtml",
    "datetime": "2022-08-17 18:00:25",
    "code": "301126"
  },
  {
    "title": "【龙虎榜】达嘉维康8月17日成交明细(dev)",
    "href": "http://stock.jrj.com.cn/2022/08/17180036908705.shtml",
    "datetime": "2022-08-17 18:00:06",
    "code": "301126"
  },
  {
    "title": "迎政策利好！A股辅助生殖概念股集体走强，汉商集团、达嘉维康涨超6%",
    "href": "http://stock.jrj.com.cn/2022/08/17092736906682.shtml",
    "datetime": "2022-08-17 09:27:21",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：聘任胡胜利担任总经理",
    "href": "http://stock.jrj.com.cn/2022/07/29215436855606.shtml",
    "datetime": "2022-07-29 21:54:56",
    "code": "301126"
  },
  {
    "title": "达嘉维康：2022年上半年归母净利润3821.08万元",
    "href": "http://stock.jrj.com.cn/2022/07/29203236855287.shtml",
    "datetime": "2022-07-29 20:32:24",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：上半年净利润增8.75%至3821.08万元",
    "href": "http://stock.jrj.com.cn/2022/07/29182436854740.shtml",
    "datetime": "2022-07-29 18:24:47",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：拟1.44亿元收购宁夏德立信51%的股权",
    "href": "http://stock.jrj.com.cn/2022/07/21173036832478.shtml",
    "datetime": "2022-07-21 17:30:51",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)拟定增募资不超1.99亿元 用于收购德立信51%股权及补流",
    "href": "http://stock.jrj.com.cn/2022/07/21172936832425.shtml",
    "datetime": "2022-07-21 17:29:43",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：2021年年度权益分派10派0.34元 股权登记日6月20日",
    "href": "http://stock.jrj.com.cn/2022/06/14185336728651.shtml",
    "datetime": "2022-06-14 18:53:31",
    "code": "301126"
  },
  {
    "title": "达嘉维康：拟与康尔佳股份等共设合资公司，进而收购医药制造业资产",
    "href": "http://stock.jrj.com.cn/2022/06/10094636718202.shtml",
    "datetime": "2022-06-10 09:46:55",
    "code": "301126"
  },
  {
    "title": "达嘉维康：拟与康尔佳股份等共设合资公司 进而收购医药制造业资产",
    "href": "http://stock.jrj.com.cn/2022/06/09183336716674.shtml",
    "datetime": "2022-06-09 18:33:41",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：拟与康尔佳股份等共设合资公司 进而收购医药制造业资产",
    "href": "http://stock.jrj.com.cn/2022/06/09180936716573.shtml",
    "datetime": "2022-06-09 18:09:57",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：266.248万股限售股将于6月7日解禁上市",
    "href": "http://stock.jrj.com.cn/2022/06/01203836698191.shtml",
    "datetime": "2022-06-01 20:38:46",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)2021年度净利升5.25%至6825.89万元 拟10派0.34元",
    "href": "http://stock.jrj.com.cn/2022/04/24190436448992.shtml",
    "datetime": "2022-04-24 19:04:12",
    "code": "301126"
  },
  {
    "title": "【龙虎榜】达嘉维康3月10日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/10180034810011.shtml",
    "datetime": "2022-03-10 18:00:10",
    "code": "301126"
  },
  {
    "title": "【龙虎榜】达嘉维康3月9日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/09180034576457.shtml",
    "datetime": "2022-03-09 18:00:35",
    "code": "301126"
  },
  {
    "title": "【龙虎榜】达嘉维康3月8日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/08180034541898.shtml",
    "datetime": "2022-03-08 18:00:09",
    "code": "301126"
  },
  {
    "title": "【龙虎榜】达嘉维康2月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/02/22180034435289.shtml",
    "datetime": "2022-02-22 18:00:40",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：拟使用1700万元超募资金永久性补充流动资金",
    "href": "http://stock.jrj.com.cn/2022/01/12223134151814.shtml",
    "datetime": "2022-01-12 22:31:33",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：拟使用不超3.5亿元闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/12/28201534077741.shtml",
    "datetime": "2021-12-28 20:15:12",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：拟使用1.5亿元募集资金对达嘉医药增资及提供不超3亿元无息借款以实施募投项目",
    "href": "http://stock.jrj.com.cn/2021/12/28201434077738.shtml",
    "datetime": "2021-12-28 20:14:20",
    "code": "301126"
  },
  {
    "title": "【龙虎榜】达嘉维康12月15日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/12/15180034020227.shtml",
    "datetime": "2021-12-15 18:00:41",
    "code": "301126"
  },
  {
    "title": "【龙虎榜】达嘉维康12月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/12/14180034015088.shtml",
    "datetime": "2021-12-14 18:00:20",
    "code": "301126"
  },
  {
    "title": "以专业药房破局，达嘉维康正式登陆创业板",
    "href": "http://stock.jrj.com.cn/2021/12/09103133988918.shtml",
    "datetime": "2021-12-09 10:31:16",
    "code": "301126"
  },
  {
    "title": "【龙虎榜】达嘉维康12月7日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/12/07180133980806.shtml",
    "datetime": "2021-12-07 18:01:02",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)IPO认购结果：网上网下共弃购4.43万股",
    "href": "http://stock.jrj.com.cn/2021/12/01210733951691.shtml",
    "datetime": "2021-12-01 21:07:06",
    "code": "301126"
  },
  {
    "title": "【兑奖啦】粤万年青、达嘉维康等三新股网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2021/11/29211333940020.shtml",
    "datetime": "2021-11-29 21:13:52",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)披露中签结果：中签号码共有5.0078万个",
    "href": "http://stock.jrj.com.cn/2021/11/29211033940001.shtml",
    "datetime": "2021-11-29 21:10:40",
    "code": "301126"
  },
  {
    "title": "达嘉维康：发行价格确定为12.37元/股 发行日期11月26日（T日）",
    "href": "http://stock.jrj.com.cn/2021/11/25181033919839.shtml",
    "datetime": "2021-11-25 18:10:32",
    "code": "301126"
  },
  {
    "title": "达嘉维康：发行价格确定为12.37元/股 发行日期11月26日（T日）",
    "href": "http://stock.jrj.com.cn/2021/11/25181033940499.shtml",
    "datetime": "2021-11-25 18:10:32",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)IPO定价为12.37元/股 11月26日申购",
    "href": "http://stock.jrj.com.cn/2021/11/24223133916126.shtml",
    "datetime": "2021-11-24 22:31:08",
    "code": "301126"
  },
  {
    "title": "达嘉维康(301126.SZ)：网上路演时间为11月25日14:00-17:00",
    "href": "http://stock.jrj.com.cn/2021/11/23205933911236.shtml",
    "datetime": "2021-11-23 20:59:54",
    "code": "301126"
  },
  {
    "title": "达嘉维康上市新进展：审核状态变更为“上市委会议通过”",
    "href": "http://stock.jrj.com.cn/2021/04/13101132363152.shtml",
    "datetime": "2021-04-13 10:11:26",
    "code": "301126"
  },
  {
    "title": "达嘉维康IPO浑身是伤：向非员工股权激励 股权交易也存疑",
    "href": "http://stock.jrj.com.cn/2021/03/26080932221241.shtml",
    "datetime": "2021-03-26 08:09:00",
    "code": "301126"
  },
  {
    "title": "达嘉维康IPO背后：药房零售毛利率落后，历史转股或存疑问",
    "href": "http://stock.jrj.com.cn/ipo/2021/03/11082332107420.shtml",
    "datetime": "2021-03-11 08:23:30",
    "code": "301126"
  },
  {
    "title": "达嘉维康旧伤未愈仍执意“奔A” 低价增发引人才遭质疑",
    "href": "http://stock.jrj.com.cn/2021/02/23235532014916.shtml",
    "datetime": "2021-02-23 23:55:33",
    "code": "301126"
  },
  {
    "title": "加快专业药房布局 达嘉维康扩大“特门服务”优势",
    "href": "http://stock.jrj.com.cn/2021/02/23132332011876.shtml",
    "datetime": "2021-02-23 13:23:37",
    "code": "301126"
  },
  {
    "title": "达嘉维康现金流常负7亿银行借款 应收款3年1期超11亿",
    "href": "http://stock.jrj.com.cn/2021/02/22070732003325.shtml",
    "datetime": "2021-02-22 07:07:00",
    "code": "301126"
  },
  {
    "title": "亚康万玮、达嘉维康、争光股份2月24日创业板首发上会",
    "href": "http://stock.jrj.com.cn/2021/02/18160031986734.shtml",
    "datetime": "2021-02-18 16:00:41",
    "code": "301126"
  },
  {
    "title": "实控人认定未能释疑：达嘉维康遭四轮均要求回答 过会率降低",
    "href": "http://stock.jrj.com.cn/2020/12/08183831441825.shtml",
    "datetime": "2020-12-08 18:38:07",
    "code": "301126"
  },
  {
    "title": "达嘉维康收创业板第三轮问询函 深交所质疑其是否符合创业板定位",
    "href": "http://stock.jrj.com.cn/2020/12/07182631432121.shtml",
    "datetime": "2020-12-07 18:26:02",
    "code": "301126"
  },
  {
    "title": "达嘉维康创业板获受理：1.5亿元募集资金用于偿还银行",
    "href": "http://stock.jrj.com.cn/2020/08/17152730519378.shtml",
    "datetime": "2020-08-17 15:27:53",
    "code": "301126"
  },
  {
    "title": "达嘉维康上半年营收9.63亿元 同比增长12.08%",
    "href": "http://stock.jrj.com.cn/2017/08/28141223013380.shtml",
    "datetime": "2017-08-28 14:12:17",
    "code": "301126"
  },
  {
    "title": "达嘉维康公司募资2.30亿元 用于补充流动资金及偿还银行贷款",
    "href": "http://stock.jrj.com.cn/2017/07/12183822739229.shtml",
    "datetime": "2017-07-12 18:38:11",
    "code": "301126"
  }
]